Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026
Globe Newswire•09/10/2026•08:50 ET
1
Key Highlights
- ➤Royalty Pharma (RPRX) will report Q3 2026 results November 4 before markets open
- ➤Conference call and webcast scheduled for 8:00 a.m. Eastern Time November 4
- ➤Portfolio includes royalties on more than 35 commercial products and 17 development-stage candidates
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2026 financial results on Wednesday, November 4, 2026 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day.
Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events/ to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company's website for at least 30 days.
Get started
Create a free account to read the full story.